Clinical Edge Journal Scan

Genetic Study Reveals Increased Mutual Risk Between PsA and Ulcerative Colitis


 

Key clinical point: A Mendelian randomization analysis revealed that psoriatic arthritis (PsA) was a significant risk factor for ulcerative colitis (UC) and vice versa.

Major finding: UC was associated with a 45.8% increased risk for PsA (odds ratio [OR] 1.458; P = .0013); conversely, PsA was associated with a 32.9% increased risk for UC (OR 1.329; P < .001).

Study details: This Mendelian randomization study evaluated the causal association between PsA, UC, and psoriasis using 123 single nucleotide polymorphisms from genome-wide association studies as genetic instrumental variables.

Disclosures: This study did not receive any specific funding. The authors declared no conflicts of interest.

Source: Pan J, Lv Y, Wang L, et al. Mendelian randomization analysis of psoriasis and psoriatic arthritis associated with risks of ulcerative colitis. Skin Res Technol. 2024;30:e13795 (Jul 12). Doi: 10.3390/jcm13154567 Source

Recommended Reading

US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives
MDedge Rheumatology
Bimekizumab Shows Promising Outcomes in PsA, With or Without Methotrexate
MDedge Rheumatology
IL-23 and IL-12/23 Inhibitors Show Comparable Safety in Preventing PsA in Psoriasis
MDedge Rheumatology
Achieving Disease Control Linked to Better Quality of Life in PsA
MDedge Rheumatology
Sparing Effect of First-Line Targeted Therapy in PsA
MDedge Rheumatology
Bimekizumab Outperforms Ustekinumab for PsA in a Matching-Adjusted Indirect Comparison
MDedge Rheumatology
Right Hand and Right Knee Joints Most Affected in PsA
MDedge Rheumatology
Autoimmune Diseases Increase PsA Risk
MDedge Rheumatology
Exercise and Mediterranean Diet Benefit Skin and Joints in PsA
MDedge Rheumatology
Ultrasound Can Detect Disease Activity in PsA Patients Apparently Within Treatment Target
MDedge Rheumatology